HEADER TRANSCRIPTION 26-OCT-06 2NPA TITLE THE CRYSTAL STRUCTURE OF THE HUMAN PPARAPLPHA LIGAND BINDING DOMAIN IN TITLE 2 COMPLEX WITH A A-HYDROXYIMINO PHENYLPROPANOIC ACID COMPND MOL_ID: 1; COMPND 2 MOLECULE: PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR ALPHA; COMPND 3 CHAIN: A, C; COMPND 4 FRAGMENT: LIGAND BINDING DOMAIN; COMPND 5 SYNONYM: PPAR-ALPHA; COMPND 6 ENGINEERED: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: SRC- PEPTIDE FROM NUCLEAR RECEPTOR COACTIVATOR 1; COMPND 9 CHAIN: B, D; COMPND 10 SYNONYM: SRC- PEPTIDE FROM STEROID RECEPTOR COACTIVATOR; COMPND 11 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 511693; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21; SOURCE 8 MOL_ID: 2; SOURCE 9 SYNTHETIC: YES; SOURCE 10 OTHER_DETAILS: CHEMICALLY SYNTHESIZED 21 MER PORTION OF THE HUMAN SOURCE 11 SRC-1 KEYWDS PROTEIN-AGONIST COMPLEX, TRANSCRIPTION EXPDTA X-RAY DIFFRACTION AUTHOR K.H.KIM,H.K.CHUNG,H.O.HAN,S.H.KIM,J.S.KOH,G.T.KIM REVDAT 4 25-OCT-23 2NPA 1 REMARK SEQADV REVDAT 3 18-OCT-17 2NPA 1 REMARK REVDAT 2 24-FEB-09 2NPA 1 VERSN REVDAT 1 30-OCT-07 2NPA 0 JRNL AUTH H.O.HAN,S.H.KIM,K.H.KIM,G.C.HUR,H.J.YIM,H.K.CHUNG,S.H.WOO, JRNL AUTH 2 K.D.KOO,C.S.LEE,J.S.KOH,G.T.KIM JRNL TITL DESIGN AND SYNTHESIS OF OXIME ETHERS OF JRNL TITL 2 ALPHA-ACYL-BETA-PHENYLPROPANOIC ACIDS AS PPAR DUAL AGONISTS JRNL REF BIOORG.MED.CHEM.LETT. V. 17 937 2007 JRNL REFN ISSN 0960-894X JRNL PMID 17157019 JRNL DOI 10.1016/J.BMCL.2006.11.050 REMARK 2 REMARK 2 RESOLUTION. 2.30 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.30 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 91.7 REMARK 3 NUMBER OF REFLECTIONS : 29052 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.220 REMARK 3 FREE R VALUE : 0.260 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 7.300 REMARK 3 FREE R VALUE TEST SET COUNT : 2323 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4452 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 64 REMARK 3 SOLVENT ATOMS : 281 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 46.98 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -1.97200 REMARK 3 B22 (A**2) : -0.69400 REMARK 3 B33 (A**2) : 2.66600 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 4.41600 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : NULL REMARK 3 BOND ANGLES (DEGREES) : NULL REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : 52.31 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : 258.PARAM REMARK 3 PARAMETER FILE 3 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 4 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 TOPOLOGY FILE 2 : NULL REMARK 3 TOPOLOGY FILE 3 : NULL REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2NPA COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 01-NOV-06. REMARK 100 THE DEPOSITION ID IS D_1000040136. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 20-FEB-04 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : MACSCIENCE REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.54 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MAC SCIENCE DIP-2030 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO, HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 29916 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.300 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 95.9 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : 0.05900 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 18.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.30 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.34 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.4 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.37600 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: PDB ENTRY 1K7L REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 55.98 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.79 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 6% PEG 10K. 0.1M HEPES, 6% ETHYLENE REMARK 280 GLYCOL, PH 7.5, VAPOR DIFFUSION, HANGING DROP REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 50.03700 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 TYR A 468 REMARK 465 ALA C 260 REMARK 465 ASN C 261 REMARK 465 GLY C 262 REMARK 465 LEU D 683 REMARK 465 THR D 684 REMARK 465 GLN D 695 REMARK 465 GLU D 696 REMARK 465 GLY D 697 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS C 257 CG CD CE NZ REMARK 470 ARG D 686 CG CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 393 69.87 -106.08 REMARK 500 ASP A 419 72.76 -106.58 REMARK 500 THR A 450 20.62 -140.22 REMARK 500 ALA A 454 49.36 -86.26 REMARK 500 THR B 684 1.10 -51.89 REMARK 500 GLU B 685 42.75 -89.12 REMARK 500 GLN B 695 -75.69 -86.41 REMARK 500 GLU B 696 -74.60 -70.30 REMARK 500 THR C 200 -173.93 -61.33 REMARK 500 SER C 230 -75.93 -84.45 REMARK 500 ASN C 299 5.99 -67.23 REMARK 500 LEU C 392 -85.09 -79.06 REMARK 500 ARG C 465 105.33 -51.41 REMARK 500 MET C 467 -88.06 -80.05 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MMB A 1201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MMB C 2201 DBREF 2NPA A 199 468 UNP Q07869 PPARA_HUMAN 199 468 DBREF 2NPA C 199 468 UNP Q07869 PPARA_HUMAN 199 468 DBREF 2NPA B 683 697 UNP Q2T9G5 Q2T9G5_HUMAN 683 697 DBREF 2NPA D 683 697 UNP Q2T9G5 Q2T9G5_HUMAN 683 697 SEQADV 2NPA ALA A 232 UNP Q07869 LYS 232 CONFLICT SEQADV 2NPA ALA C 232 UNP Q07869 LYS 232 CONFLICT SEQRES 1 A 270 GLU THR ALA ASP LEU LYS SER LEU ALA LYS ARG ILE TYR SEQRES 2 A 270 GLU ALA TYR LEU LYS ASN PHE ASN MET ASN LYS VAL LYS SEQRES 3 A 270 ALA ARG VAL ILE LEU SER GLY ALA ALA SER ASN ASN PRO SEQRES 4 A 270 PRO PHE VAL ILE HIS ASP MET GLU THR LEU CYS MET ALA SEQRES 5 A 270 GLU LYS THR LEU VAL ALA LYS LEU VAL ALA ASN GLY ILE SEQRES 6 A 270 GLN ASN LYS GLU ALA GLU VAL ARG ILE PHE HIS CYS CYS SEQRES 7 A 270 GLN CYS THR SER VAL GLU THR VAL THR GLU LEU THR GLU SEQRES 8 A 270 PHE ALA LYS ALA ILE PRO GLY PHE ALA ASN LEU ASP LEU SEQRES 9 A 270 ASN ASP GLN VAL THR LEU LEU LYS TYR GLY VAL TYR GLU SEQRES 10 A 270 ALA ILE PHE ALA MET LEU SER SER VAL MET ASN LYS ASP SEQRES 11 A 270 GLY MET LEU VAL ALA TYR GLY ASN GLY PHE ILE THR ARG SEQRES 12 A 270 GLU PHE LEU LYS SER LEU ARG LYS PRO PHE CYS ASP ILE SEQRES 13 A 270 MET GLU PRO LYS PHE ASP PHE ALA MET LYS PHE ASN ALA SEQRES 14 A 270 LEU GLU LEU ASP ASP SER ASP ILE SER LEU PHE VAL ALA SEQRES 15 A 270 ALA ILE ILE CYS CYS GLY ASP ARG PRO GLY LEU LEU ASN SEQRES 16 A 270 VAL GLY HIS ILE GLU LYS MET GLN GLU GLY ILE VAL HIS SEQRES 17 A 270 VAL LEU ARG LEU HIS LEU GLN SER ASN HIS PRO ASP ASP SEQRES 18 A 270 ILE PHE LEU PHE PRO LYS LEU LEU GLN LYS MET ALA ASP SEQRES 19 A 270 LEU ARG GLN LEU VAL THR GLU HIS ALA GLN LEU VAL GLN SEQRES 20 A 270 ILE ILE LYS LYS THR GLU SER ASP ALA ALA LEU HIS PRO SEQRES 21 A 270 LEU LEU GLN GLU ILE TYR ARG ASP MET TYR SEQRES 1 B 15 LEU THR GLU ARG HIS LYS ILE LEU HIS ARG LEU LEU GLN SEQRES 2 B 15 GLU GLY SEQRES 1 C 270 GLU THR ALA ASP LEU LYS SER LEU ALA LYS ARG ILE TYR SEQRES 2 C 270 GLU ALA TYR LEU LYS ASN PHE ASN MET ASN LYS VAL LYS SEQRES 3 C 270 ALA ARG VAL ILE LEU SER GLY ALA ALA SER ASN ASN PRO SEQRES 4 C 270 PRO PHE VAL ILE HIS ASP MET GLU THR LEU CYS MET ALA SEQRES 5 C 270 GLU LYS THR LEU VAL ALA LYS LEU VAL ALA ASN GLY ILE SEQRES 6 C 270 GLN ASN LYS GLU ALA GLU VAL ARG ILE PHE HIS CYS CYS SEQRES 7 C 270 GLN CYS THR SER VAL GLU THR VAL THR GLU LEU THR GLU SEQRES 8 C 270 PHE ALA LYS ALA ILE PRO GLY PHE ALA ASN LEU ASP LEU SEQRES 9 C 270 ASN ASP GLN VAL THR LEU LEU LYS TYR GLY VAL TYR GLU SEQRES 10 C 270 ALA ILE PHE ALA MET LEU SER SER VAL MET ASN LYS ASP SEQRES 11 C 270 GLY MET LEU VAL ALA TYR GLY ASN GLY PHE ILE THR ARG SEQRES 12 C 270 GLU PHE LEU LYS SER LEU ARG LYS PRO PHE CYS ASP ILE SEQRES 13 C 270 MET GLU PRO LYS PHE ASP PHE ALA MET LYS PHE ASN ALA SEQRES 14 C 270 LEU GLU LEU ASP ASP SER ASP ILE SER LEU PHE VAL ALA SEQRES 15 C 270 ALA ILE ILE CYS CYS GLY ASP ARG PRO GLY LEU LEU ASN SEQRES 16 C 270 VAL GLY HIS ILE GLU LYS MET GLN GLU GLY ILE VAL HIS SEQRES 17 C 270 VAL LEU ARG LEU HIS LEU GLN SER ASN HIS PRO ASP ASP SEQRES 18 C 270 ILE PHE LEU PHE PRO LYS LEU LEU GLN LYS MET ALA ASP SEQRES 19 C 270 LEU ARG GLN LEU VAL THR GLU HIS ALA GLN LEU VAL GLN SEQRES 20 C 270 ILE ILE LYS LYS THR GLU SER ASP ALA ALA LEU HIS PRO SEQRES 21 C 270 LEU LEU GLN GLU ILE TYR ARG ASP MET TYR SEQRES 1 D 15 LEU THR GLU ARG HIS LYS ILE LEU HIS ARG LEU LEU GLN SEQRES 2 D 15 GLU GLY HET MMB A1201 32 HET MMB C2201 32 HETNAM MMB (2R,3E)-2-{4-[(5-METHYL-2-PHENYL-1,3-OXAZOL-4-YL) HETNAM 2 MMB METHOXY]BENZYL}-3-(PROPOXYIMINO)BUTANOIC ACID HETSYN MMB (R,E)-2-(4-((5-METHYL-2-PHENYLOXAZOL-4-YL)METHOXY) HETSYN 2 MMB BENZYL)-3-(PROPOXYIMINO)BUTANOIC ACID FORMUL 5 MMB 2(C25 H28 N2 O5) FORMUL 7 HOH *281(H2 O) HELIX 1 1 THR A 200 PHE A 218 1 19 HELIX 2 2 ASN A 221 GLY A 231 1 11 HELIX 3 3 ASP A 243 ASN A 261 1 19 HELIX 4 4 GLU A 267 ALA A 293 1 27 HELIX 5 5 ASP A 301 SER A 322 1 22 HELIX 6 6 SER A 323 MET A 325 5 3 HELIX 7 7 ALA A 333 GLY A 335 5 3 HELIX 8 8 ARG A 341 LEU A 347 1 7 HELIX 9 9 PRO A 350 ILE A 354 5 5 HELIX 10 10 MET A 355 ALA A 367 1 13 HELIX 11 11 ASP A 371 CYS A 384 1 14 HELIX 12 12 ASN A 393 HIS A 416 1 24 HELIX 13 13 PHE A 421 LYS A 449 1 29 HELIX 14 14 HIS A 457 ARG A 465 1 9 HELIX 15 15 HIS B 687 GLU B 696 1 10 HELIX 16 16 THR C 200 PHE C 218 1 19 HELIX 17 17 ASN C 221 LEU C 229 1 9 HELIX 18 18 ASP C 243 LEU C 254 1 12 HELIX 19 19 LEU C 254 VAL C 259 1 6 HELIX 20 20 GLU C 267 ILE C 294 1 28 HELIX 21 21 ASP C 301 SER C 322 1 22 HELIX 22 22 ARG C 341 LEU C 347 1 7 HELIX 23 23 PRO C 350 ILE C 354 5 5 HELIX 24 24 MET C 355 LEU C 368 1 14 HELIX 25 25 ASP C 371 CYS C 384 1 14 HELIX 26 26 ASN C 393 HIS C 416 1 24 HELIX 27 27 PHE C 421 GLU C 451 1 31 HELIX 28 28 HIS C 457 ARG C 465 1 9 HELIX 29 29 HIS D 687 LEU D 694 1 8 SHEET 1 A 3 PHE A 239 ILE A 241 0 SHEET 2 A 3 GLY A 337 THR A 340 1 O PHE A 338 N ILE A 241 SHEET 3 A 3 GLY A 329 VAL A 332 -1 N MET A 330 O ILE A 339 SHEET 1 B 4 PHE C 239 ILE C 241 0 SHEET 2 B 4 GLY C 337 THR C 340 1 O PHE C 338 N ILE C 241 SHEET 3 B 4 GLY C 329 VAL C 332 -1 N MET C 330 O ILE C 339 SHEET 4 B 4 MET C 325 ASN C 326 -1 N ASN C 326 O GLY C 329 CISPEP 1 LYS A 349 PRO A 350 0 0.06 CISPEP 2 LYS C 349 PRO C 350 0 -0.18 SITE 1 AC1 14 ILE A 272 PHE A 273 CYS A 275 CYS A 276 SITE 2 AC1 14 GLN A 277 SER A 280 TYR A 314 LEU A 321 SITE 3 AC1 14 VAL A 332 ILE A 354 MET A 355 HIS A 440 SITE 4 AC1 14 TYR A 464 HOH A1203 SITE 1 AC2 11 PHE C 273 CYS C 276 SER C 280 TYR C 314 SITE 2 AC2 11 LEU C 321 VAL C 332 ILE C 354 HIS C 440 SITE 3 AC2 11 LEU C 460 TYR C 464 HOH C2209 CRYST1 59.909 100.074 61.311 90.00 100.14 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.016692 0.000000 0.002985 0.00000 SCALE2 0.000000 0.009993 0.000000 0.00000 SCALE3 0.000000 0.000000 0.016569 0.00000